Xenetic Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021
Xenetic Biosciences, Inc. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced total revenue was USD 191,216 compared to USD 56,749 a year ago. Operating loss was USD 1.369 million compared to USD 1.230 million a year ago. Net loss was USD 1.345 million compared to USD 1.179 million a year ago. Basic loss per share from continuing operations was USD 0.15 compared to USD 0.19 a year ago.